By 21–24 weeks after COVID-19 onset, participants with ongoing PASC at 24 weeks after COVID-19 onset had higher concentrations of CRP in multivariable analyses compared to participants without PASC (Fig 3). This evidence concerns the gene CRP and COVID-19.